Gynecology without delivery services is structurally an area that is easy to enter with growing demand.
Clinics declaring obstetrics and gynecology number 2,784 nationally — about 2.7% of all clinics — with 4,109 obstetrician-gynecologists in clinic practice (roughly 3.8% of clinic physicians), positioning it as a specialty with few competing clinics. Outpatient-focused practice without deliveries requires no large site, parking, or overnight coverage, allowing small bed-free openings in high-traffic locations near stations — lowering the barrier further.
1. Macro environment — femtech as a tailwind
On demand, the expanding femtech and femcare market addressing women's health provides a tailwind. The 2024 femcare and femtech market (consumer goods and services) reached ¥80.39 billion, still expanding despite the initial boom having run its course.
Separate research on femtech as a women's healthcare and medical field projects continued growth in corporate and municipal channels — centered on women's PHR such as menstrual tracking apps, online health consultation, and mail-in testing — against the backdrop of government priorities on women's advancement and gender equality.
This social visibility of women's health lowers the barrier to gynecology visits, surfacing populations that previously did not seek care for dysmenorrhea, PMS, and menopausal symptoms.
On regulation, the FY2026 fee revision has taken effect. In obstetrics, how to institutionalize reduced childbirth cost burden is the dominant question — but that concerns delivery-handling facilities. For outpatient gynecology, the practical focus is how to design accounting operations across mixed insured, self-pay, and publicly funded care.
2. Characteristics of newly opened clinics
First, location and scale. Where delivery facilities need large sites, parking, and proximity to the director's residence, outpatient gynecology finds its fit in high-traffic locations near stations, with small bed-free tenant practices as the mainstream. Lower initial investment and fixed costs than delivery-handling practices mean reaching break-even sooner — the economic reason outpatient-focused models get chosen.
Second, being a woman physician is itself a strong differentiator and acquisition factor. Patients tend to search "location plus woman physician," and SEO ensuring the website appears for that search is recommended practice. Given the sensitivity of the concerns involved, clinics foregrounding care by women physicians have opened across the country, and together with web booking, cashless payment, and privacy-conscious flow design, they compete on patient experience itself.
Third, more practices design a revenue portfolio combining insured care, self-pay, and online consultation from the opening stage. Alongside insured pillars (dysmenorrhea, endometriosis, menopause, cancer screening), they add online prescribing of contraceptives and emergency contraception, bridal checks, and aesthetic dermatology and gynecology menus — deliberately raising the self-pay share.
But this composition breaks down operationally when the boundary between insured, self-pay, and publicly funded care blurs, so organizing price lists, consent forms, billing system configuration, and KPIs for receivables management from the start is emphasized as essential.
3. Revenue areas specific to gynecology
The revenue base divides into chronically recurring conditions within insured care, and regular screening and prevention.
Dysmenorrhea and endometriosis (insured)
Low-dose estrogen-progestin combination therapy (LEP) is insured for dysmenorrhea, shifting care from analgesic-centered management to continuing disease management with hormonal therapy. Dysmenorrhea and endometriosis generate continuing visits among younger and reproductive-age patients, forming a stable outpatient base. Clearly separating insured LEP from self-pay contraceptive prescribing matters operationally.
Menopause and HRT (insured plus self-pay)
Hormone replacement therapy for menopausal symptoms was reaffirmed as standard treatment with publication of the 2025 Hormone Replacement Therapy Guidelines by the Japan Society of Obstetrics and Gynecology and the Japan Society for Menopause and Women's Health.
Meanwhile, HRT penetration in Japan is low relative to Western countries — which conversely means substantial unmet demand and growth potential. More clinics are launching self-pay menopause clinics and menopause screening packages combining HRT, kampo, and lifestyle guidance.
Cervical and endometrial screening, HPV
Cervical cancer screening is at a major regulatory turning point. From April 2024, municipalities meeting MHLW requirements may conduct "HPV primary screening" as population screening. MHLW surveys report that 337 municipalities plan to introduce HPV testing in public screening. Self-collected HPV testing is also under consideration as a participation-raising measure.
Screening generates revenue directly and functions as the pathway into workup, treatment, and vaccination. HPV vaccination continues to require handling of catch-up-eligible cohorts following the resumption of proactive recommendation, and delivering screening and vaccination together is a gynecology strength.
PMS and menstrual tracking app integration
Menstrual tracking and PHR apps are a core femtech category, and more patients bring app-recorded cycle and symptom data into consultations. Linking apps with online consultation for pre-visit information gathering and medication follow-up is spreading.
4. Self-pay services
In outpatient gynecology, self-pay is central to both revenue and differentiation.
| Area | Overview | Business considerations |
|---|---|---|
| Low-dose contraceptives | Self-pay when for contraception; high lifetime value through ongoing prescription | Must be designed to compete with and complement online prescribing |
| Emergency contraception | Historically self-pay, in-clinic or online prescribing | 2026 OTC availability structurally changes the competitive environment |
| Bridal checks / preconception care | Packages of pre-pregnancy infectious disease, hormone, and cancer screening | High unit value; a new touchpoint with younger patients |
| Aesthetic gynecology / GSM care | Vaginal and intimate area lasers; genitourinary syndrome of menopause | A natural pathway from the menopause clinic |
| Attached aesthetic dermatology | Lasers, doctor's cosmetics | Raises visit frequency and revenue per patient |
| Self-pay testing | HPV, STI, and mail-in testing | Entry point into screening and treatment |
OTC emergency contraception as a structural change
Over-the-counter availability of emergency contraception advanced in 2026, with over 10,000 pharmacies nationwide reported as carrying it.
This means some emergency contraception encounters shift from clinics to pharmacies, requiring reassessment of any premise treating emergency contraception alone as a revenue source.
At the same time, improved access raises interest in contraception generally, making it an opportunity for gynecology practices able to build the continuing relationship that follows — regular contraception, cycle management, ongoing low-dose pill prescription.
Low-dose contraceptives and online consultation
Online contraceptive prescribing has become a mature market with multiple competing players, competing directly with in-person clinics on price and convenience. Individual gynecology clinics prescribing contraceptives and emergency contraception through their own online consultation has become common.
Bridal checks and preconception care
Self-pay testing packages ahead of marriage and pregnancy are widely productized, combining infectious disease, hormone, uterine and ovarian ultrasound, and cancer screening. They align well with national promotion of preconception care and are expanding as a high-value self-pay menu creating new touchpoints with younger patients.
Aesthetic gynecology and GSM care
Rising interest in genitourinary syndrome of menopause — vaginal dryness, atrophy, urinary symptoms — has led more clinics to offer dedicated clinics and intimate area laser treatment as self-pay. As a pathway from the menopause clinic, and combined with attached aesthetic dermatology, it is growing into a self-pay revenue pillar.
5. Management implications
Outpatient gynecology is an attractive area to enter: relatively few competing facilities, social tailwinds from femtech and women's health, and easy small, bed-free openings near stations.
But a simple "wait for insured patients to arrive" model risks having revenue eroded by online prescribing and pharmacy OTC availability. The winning approach is a layered portfolio:
- Build a stable insured base in continuing conditions — dysmenorrhea, endometriosis, menopause
- Secure the prevention entry point through screening, HPV, and vaccination
- Layer self-pay heavily — bridal checks, HRT, GSM, aesthetic gynecology
- Differentiate on patient experience through women physicians, privacy consideration, web booking, and online consultation
At the same time, unless accounting operations across mixed insured, self-pay, and publicly funded care are organized from the start — price lists, consent forms, billing system configuration, KPIs for receivables and unit price variance — the front line breaks down the moment revenue becomes complex.
OTC emergency contraception and mainstream online prescribing are threats and, simultaneously, opportunities that activate women's care-seeking overall. Whether you can shift your center of gravity from one-off prescriptions to building continuing relationships is the dividing line.
6. How an AI EMR addresses these problems — feature by feature
The shift outpatient gynecology faces — from one-off prescriptions to continuing relationships — is, at bottom, a design problem in documentation, accounting, and patient communication. Here is how Pottech's AI Karte supports that design, feature by feature.
Feature 1: Patient PHR app integration ("Pote-kun") — turn one-off prescriptions into relationships
Appointment booking, medication reminders, pre-visit web questionnaires, fee notifications and digital receipts, and LINE login with push notifications.
The dominant management problem here is erosion of one-off prescription revenue by OTC emergency contraception and the rise of online-only players. The answer is not price competition but conversion to continuing relationships.
Ongoing low-dose pill prescription presupposes monthly adherence, where reminders determine continuation. Recall for cervical cancer screening is a direct lever on the roughly 35% participation rate. Outreach to cohorts affected by the end of HPV vaccination catch-up runs the same way. Whether a mechanism exists that naturally creates patient-side touchpoints changes the ground on which you compete with online-only players.
Feature 2: Integrations and APIs — turn menstrual app data into a clinical asset
An OAuth2 gateway, MCP server, HAPI FHIR, and the LINE Messaging API.
Menstrual tracking and PHR apps are a core femtech category, and more patients bring app-recorded cycle and symptom data into consultations. Ingesting that as structured data into the EMR makes it usable in decisions about ongoing LEP and HRT prescription and functions as pre-visit information gathering.
Asking again in the consultation room for information the patient has already recorded is a clear loss in a specialty competing on patient experience.
Feature 3: Billing and claims — automatically sort insured, self-pay, and publicly funded care
An automated calculation engine checks bundling conflicts, exclusions, and frequency limits, and determines eligibility automatically.
Accounting here is complex. LEP is insured for dysmenorrhea and self-pay for contraception. Cervical screening is publicly funded through municipal programs and self-pay when elective. Add HPV testing, STI testing, and bridal check packages, and the same patient moves across multiple categories.
The repeated warning that operations break down when the boundary between insured, self-pay, and publicly funded care blurs stems from this structure. Enforcing the distinction in the system serves both mixed billing avoidance and receivables management.
Feature 4: Booking and reception — patient experience is the competitive axis
In-person and online bookings are managed together with segmented slot management.
In a specialty handling sensitive concerns, the experience from booking through checkout is itself a differentiator. Being able to book without describing symptoms verbally by phone; not spending long periods in the waiting room; clearly seeing which days women physicians are available.
At the same time, short return visits such as contraceptive prescription must be managed on the same calendar as long consultations such as bridal checks and first menopause visits. Unified management of online and in-person care is also a precondition for hybrid operation.
Feature 5: Charting and orders — don't let documentation interrupt a consultation built on conversation
AI generates SOAP notes from consultation audio, and questionnaires are digitized automatically.
Gynecology consultations involve listening to what patients find difficult to discuss — menstruation, pregnancy, sexuality, menopause. Time the physician spends facing a keyboard is time the patient stops talking.
Capturing cycle, symptoms, history, and medications in structured form through a pre-visit questionnaire lets the consultation focus on the actual conversation. In a specialty with heavy first-visit information volume, the effect is pronounced.
Feature 6: Document generation — standardize self-pay explanation and consent
AI generates medical documents from patient data, with registered templates preserving the clinic's format.
Bridal check package contents, HRT risk-benefit explanation, GSM care costs and course. Self-pay menus require disclosure of content, cost, and risk under the medical advertising guidelines as well. Generating explanation documents, consent forms, and price lists from one source prevents the most common failure: inconsistency between them.
Feature 7: Practice analytics — measure self-pay share and continuation rates
Visit volume, revenue per patient, monthly trends, and patient attributes are aggregated and visualized automatically.
Adopting a composition that deliberately raises the self-pay share is not design unless that share and its profitability are measured. Contraceptive continuation rates, conversion from screening into workup and treatment, the pathway from menopause clinics into self-pay menus.
In a phase where OTC availability and online prescribing erode one-off revenue, net growth in continuing patients becomes the most important operating metric. Watching total revenue alone leaves you blind to a thinning base.
Primary sources
- Yano Research Institute, "Femcare and femtech (consumer goods and services) market survey (2025)" https://www.yano.co.jp/press/press.php/003950
- Yano Research Institute, "Femtech (women's healthcare and medical) market survey (2025)" https://www.yano.co.jp/press-release/show/press_id/3940
- DtoD Concierge, "Obstetrics and gynecology clinic opening trends" https://www.dtod.ne.jp/kaigyo-topics/trend/sanfujinka.php
- m-assets, "What does the 2026 revision mean for obstetrics and gynecology?" https://m-assets.com/lp/clinic/blog/fujinka-clinic-revenue-strategy
- National Cancer Center Institute for Cancer Control, "HPV primary screening leaflet" https://canscreen.ncc.go.jp/for_pic/leaflet_detail/primary_hpv_screening.html
- Nikkei, "337 municipalities plan to introduce HPV testing in public screening — MHLW survey" https://www.nikkei.com/article/DGKKZO90161830R20C25A7CT0000/
- MHLW, "Please learn about the HPV vaccine" https://www.mhlw.go.jp/stf/houdou_kouhou/kouhou_shuppan/magazine/202205_00001.html
- Kanehara Shuppan, "Hormone Replacement Therapy Guidelines, 2025 edition" https://www.kanehara-shuppan.co.jp/books/detail.html?isbn=9784307301589
- PR TIMES / Buzzbait, "Mapping pharmacies carrying emergency contraception (13,006 locations)" https://prtimes.jp/main/html/rd/p/000000005.000112497.html
- Credo Medical, "FY2026 medical management fees for online consultation" https://www.credo-m.co.jp/column/detail/hosyu/7770/